3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Leukemia
2
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
Cyclophosphamide
13
fludarabine
11
Mycophenolic Acid
9
Busulfan
8
fludarabine phosphate
7
Tacrolimus
7
pirtobrutinib
6
Whole-Body Irradiation
6
Rituximab
6
Melphalan
6
Imatinib Mesylate
5
Bone Marrow Transplantation
5
ponatinib
4
Mesna
4
Granulocyte Colony-Stimulating Factor
4
Azacitidine
4
venetoclax
3
nilotinib
3
lintuzumab
3
Stem Cell Transplantation
3
Sirolimus
3
Platelet Transfusion
3
Methotrexate
3
Cytarabine
3
Cyclosporine
3
Alemtuzumab
3
vosaroxin
2
ruxolitinib
2
ibrutinib
2
Thiotepa
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Diseases
×
Sertraline
×
Other hematologic neoplasm
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled